Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNFα Treatment

Clicks: 415
ID: 114701
2017
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Acute lymphoblastic leukemias (ALL) positive for KMT2A/AFF1 (MLL/AF4) translocation, which constitute 60% of all infant ALL cases, have a poor prognosis even after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This poor prognosis is due to one of two factors, either r …
Reference Key
h2017canceramlexanox Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tamai H;Yamaguchi H;Miyake K;Takatori M;Kitano T;Yamanaka S;Yui S;Fukunaga K;Nakayama K;Inokuchi K;;
Journal Cancer research
Year 2017
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.